Goreisan as a successful adjuvant therapy of heart failure with preserved ejection fraction and advanced chronic kidney disease: a case report

The efficacy and safety of Wulingsan modified formulas for chronic heart failure patients: a systematic review and meta-analysis

(2022) Ziyun Li et al.   Journal of Thoracic Disease

Amelioration of Hypertension by Oryeongsan through Improvements of Body Fluid and Sodium Balance: Roles of the Renin-Angiotensin System and Atrial Natriuretic Peptide System

(2022) You Mee Ahn et al.   Evidence-based Complementary and Alternative Medicine

Impact of Goreisan upon aquaporin-2-incorporated aquaresis system in patients with congestive heart failure

(2022) Kota Kakeshita et al.   CEN Case Reports

Medical Therapy for Functional Mitral Regurgitation

(2022) Assi Milwidsky et al.   Circulation-Heart Failure

2021 ESC/EACTS Guidelines for the management of valvular heart disease

(2021) Alec Vahanian et al.   EUROPEAN HEART JOURNAL

Kampo medicine for the holistic approach to older adults with heart failure

(2021) Hidenori Yaku et al.   Journal of Cardiology

Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure

(2021) Zorba Blázquez‐Bermejo et al.   ESC Heart Failure

Goreisan Inhibits Upregulation of Aquaporin 4 and Formation of Cerebral Edema in the Rat Model of Juvenile Hypoxic-Ischemic Encephalopathy

(2017) Yoshiaki Yano et al.   Evidence-based Complementary and Alternative Medicine

Aquaporin-4 in the heart: expression, regulation and functional role in ischemia

(2012) Arkady Rutkovskiy et al.   BASIC RESEARCH IN CARDIOLOGY